| Volume
6, Number 6, Supplement / 2004
Pages S1-S2
L.M. Refolo and H.M. Fillit
New directions in neuroprotection: Basic mechanisms, molecular
targets and treatment strategies
Pages S3-S6
Dale E. Bredesen
Toward a mechanistic taxonomy of cell death programs
Pages S7-S11
Moses V. Chao and Francis S. Lee
Neurotrophin survival signaling mechanisms
Pages S13-S17
Frank M. Longo and Stephen M. Massa
Neurotrophin-based strategies for neuroprotection
Pages S19-S25
J. Kelleher-Andersson
Neurogenesis as a potential therapeutic strategy for neurodegenerative
disorders
Pages S27-S35
Roberta Diaz Brinton
Requirements of a brain selective estrogen: Advances and remaining
challenges for developing a NeuroSERM
Pages S37-S41
Illana Gozes and Inna Divinski
The femtomolar-acting NAP interacts with microtubules: Novel aspects
of astrocyte protection
Pages S43-S46
L.A. Henricksen and H.J. Federoff
Redefining neuroprotective gene therapeutic strategies: Lessons
learned from caloric restriction and NAD^+ metabolism
Pages S47-S52
Julie K. Andersen
Iron dysregulation and Parkinson's disease
Pages S53-S59
George Bartzokis, Po H. Lu, Jim Mintz
Quantifying Age-Related Myelin Breakdown with MRI: Novel Therapeutic
Targets for Preventing Cognitive Decline and Alzheimer's Disease
Pages S61-S74
Stuart A. Lipton
Paradigm shift in NMDA receptor antagonist drug development: Molecular
mechanism of uncompetitive inhibition by memantine in the treatment of
Alzheimer's disease and other neurologic disorders
Pages S75-S84
Gregory R.J. Thatcher, Brian M. Bennett, Hans. C. Dringenberg, et al.
Novel nitrates as NO mimetics directed at Alzheimer's disease
Pages S85-S92
Jerry J. Buccafusco, J. Warren Beach, Alvin V. Terry, Jr., et al.
Novel analogs of choline as potential neuroprotective agents
Pages S93-S97
Alan I. Faden, Susan M. Knoblach, Vilen A. Movsesyan, et al.
Novel small peptides with neuroprotective and nootropic properties
RETURN
TO INDEX
top |
an IOS Press publication
